Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03674229 · ClinicalTrials.gov registry record · NA
Patients Navigators in Facilitating Weight Management in Obese Participants
A NA study of Obesity and Health Status Unknown, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 171
- Enrollment target
- 1
- Study location
NCT03674229: Active NA study of Obesity and Health Status Unknown, sponsored by M.D. Anderson Cancer Center.
NCT03674229 is a NA study of Obesity and Health Status Unknown that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 171 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03674229, a NA study of Obesity and Health Status Unknown, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the effectiveness of patient navigators in facilitating weight management in obese participants. Health coaches or patient navigators may help more participants take part in weight management programs.
Primary Outcome
We will compare differences in the proportion of self-reported enrollment in any program between intervention and control groups.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Informational Intervention
- BEHAVIORAL Telephone-Based Intervention
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2015-07-02 |
| Est. Completion | 2030-10-01 |
| Phase | NA |
What the registry record for NCT03674229 still lists
NCT03674229 is an interventional study that assigns participants to a tested intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03674229 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03674229 about?
NCT03674229 is a clinical study titled "Patients Navigators in Facilitating Weight Management in Obese Participants". This trial studies the effectiveness of patient navigators in facilitating weight management in obese participants. Health coaches or patient navigators may help more participants take part in weight management programs.
What is the current status of trial NCT03674229?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 171 participants. The study started on 2015-07-02. Estimated completion is 2030-10-01.
What conditions does trial NCT03674229 study?
This clinical trial studies the following conditions: Obesity, Health Status Unknown.
What interventions are being tested in trial NCT03674229?
The interventions under investigation include: Questionnaire Administration (OTHER), Informational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03674229?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03674229 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03674229's enrollment target sits among peer trials
171 354th of 1053 higher than 699 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02641145 · 171 participants · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
- NCT05541029 · 171 participants · NA
Music Listening: A Mechanistic Trial
- NCT05561127 · 171 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
- NCT05592938 · 171 participants · NA
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI